RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection
Tauopathies are a group of neurodegenerative diseases characterized by the alteration/aggregation of TAU protein. One of the main challenges of these diseases is that they have neither biomarkers nor pharmacological targets to stop the neurodegenerative process. Apart from the neurodegenerative proc...
Saved in:
Main Authors: | Ignacio Silva-Llanes, Enrique Madruga, Ana Martínez, Isabel Lastres-Becker |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2024.1530809/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of hepatocyte RIPK1 in maintaining liver homeostasis during metabolic challenges
by: Weigao Zhang, et al.
Published: (2025-01-01) -
RIPK1 in necroptosis and recent progress in related pharmaceutics
by: Kunhou Yao, et al.
Published: (2025-02-01) -
Understanding retinal tau pathology through functional 2D and 3D iPSC-derived in vitro retinal models
by: Lorenza Mautone, et al.
Published: (2025-01-01) -
Performance of a Two-Week Rehabilitation Improves Motor Function in Inpatients with Progressive Supranuclear Palsy: A Pre–Post Study
by: Naomi Matsuda, et al.
Published: (2025-01-01) -
Iron deposition is associated with motor and non-motor network breakdown in parkinsonism
by: Fangda Leng, et al.
Published: (2025-01-01)